Can a diabetes drug fix lingering health issues after adrenal surgery?
NCT ID NCT07573163
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests whether the drug tirzepatide can improve blood pressure, weight, and blood sugar in people who still have metabolic problems after surgery to remove an adrenal gland. The condition, mild autonomous cortisol secretion (MACS), causes high blood pressure, diabetes, and weight gain. About 34 adults who have had or will have this surgery will be randomly assigned to receive tirzepatide or standard care. The goal is to see if the drug helps control these lingering health issues better than surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENALECTOMY; STATUS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a drug tame excess cortisol in a common hormone disorder?
- Adrenal surgery helps blood pressure in hormone disorder, but many still need meds
- Can a diabetes drug replace surgery for a rare hormone disorder?
- Researchers hunt for best test to spot hidden hormone problem in adrenal tumors
- Drug showdown: which pill tames cortisol better?
- New drug targets hidden hormone problem to boost heart and bone health